Why Should We Deprescribe Anticholinergics?

Patient Concerns About Deprescribing: How to Address Them

How to Taper Anticholinergic Medications Safely

Are There Guidelines for Deprescribing Anticholinergics?

Patient Case Studies: Successful Deprescription of Anticholinergics

How Do Emerging Muscarinic Agonists Like KarXT Affect Anticholinergic Use?

Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

CME: Optimizing the Utility of Muscarinic Acetylcholine Receptor Activators in Clinical Practice

CME: Interpreting the Latest Clinical Data and Treatment Implications for Approved and Emerging Muscarinic Acetylcholine Receptor Activators in Schizophrenia

CME: Understanding Muscarinic Acetylcholine Receptor Activation as a Therapeutic Target in Schizophrenia